Patents by Inventor Gerald L. Chrisope

Gerald L. Chrisope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040161480
    Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.
    Type: Application
    Filed: February 9, 2004
    Publication date: August 19, 2004
    Applicant: In Clover, Inc.
    Inventors: Rebecca Rose, Gerald L. Chrisope
  • Patent number: 6709682
    Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.
    Type: Grant
    Filed: January 8, 2002
    Date of Patent: March 23, 2004
    Assignee: In Clover, Inc.
    Inventors: Rebecca Rose, Gerald L. Chrisope
  • Patent number: 6468526
    Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: October 22, 2002
    Assignee: GyneLogix, Inc.
    Inventor: Gerald L. Chrisope
  • Publication number: 20020090365
    Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 11, 2002
    Applicant: GyneLogix, Inc.
    Inventor: Gerald L. Chrisope
  • Publication number: 20020064568
    Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.
    Type: Application
    Filed: January 8, 2002
    Publication date: May 30, 2002
    Applicant: Clover, Inc.
    Inventors: Rebecca Rose, Gerald L. Chrisope
  • Patent number: 6372209
    Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.
    Type: Grant
    Filed: January 5, 2000
    Date of Patent: April 16, 2002
    Assignee: Gyne Logix, Inc.
    Inventor: Gerald L. Chrisope
  • Patent number: 6344220
    Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: February 5, 2002
    Assignee: In Clover, Inc.
    Inventors: Rebecca Rose, Gerald L. Chrisope
  • Patent number: 6093394
    Abstract: Disclosed are novel isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicant. Also disclosed are medicants containing such Lactobacilli, a novel preservation matrix for microorganisms, a method for preserving microbial cells within a medicant, and methods for preventing and treating vaginal and gastrointestinal infections.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: July 25, 2000
    Assignee: GyneLogix, Inc.
    Inventor: Gerald L. Chrisope
  • Patent number: 5916565
    Abstract: A composition and method of use is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition is preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that act to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: June 29, 1999
    Assignee: In Clover, Inc.
    Inventors: Rebecca Rose, Gerald L. Chrisope
  • Patent number: 5279964
    Abstract: The present invention is directed to an inoculation device including an easily manipulated handle together with microorganisms associated with a device for transferring and storing for extending periods stabilized, known microorganisms. This device is particularly useful in testing standard laboratory culture media. This device is easily produced by associating known microorganisms, either alone or together with a binding agent and other biologically acceptable additives and preservatives, with the sample transfer portion of the inoculation device. When substantially all of the water is removed from an inoculation device, including known microorganisms, the microbial containing device is storable for extended periods under sterile, dry conditions substantially free of water.
    Type: Grant
    Filed: November 8, 1991
    Date of Patent: January 18, 1994
    Assignee: Chrisope Technologies, Inc.
    Inventor: Gerald L. Chrisope
  • Patent number: 5155039
    Abstract: The present invention is directed to systems and methods for preserving, transporting, storing, re-hydrating and delivering viable micro-organisms. More particularly, the present invention is directed to a kit and method for preserving and storing dried, microbiological organisms and for re-hydrating and delivering specific and reproducible numbers of viable organisms therefrom. The kit and method of the present invention provides the capability to deliver a known quantity of rehydrated micro-organisms as a single, total dose of cells without the inaccuracies and safety hazards associated with standard needle, syringe or pipette transfer systems. The kit includes first and second vial and cap combinations, the first carrying the dried organisms in a dry, biologically inert atmosphere, the second carrying a pre-measured quantity of re-hydrating fluid. A quantitative number of selected microbiological organisms are dried under mild conditions, i.e.
    Type: Grant
    Filed: July 22, 1991
    Date of Patent: October 13, 1992
    Assignee: Chrisope Technologies, Inc.
    Inventors: Gerald L. Chrisope, Nell C. Roberts
  • Patent number: 4458019
    Abstract: This invention is directed to a method and system of obtaining a culture and placing the culture in a gaseous environment for transporting and incubating the culture. The method and system includes a fixed or portable small cylinder of a desired gaseous mixture, a nozzle secured to the outlet valve of the cylinder, a plurality of different sized zip-lock bags and a plurality of petri dishes or an equivalent type means for growing a culture.
    Type: Grant
    Filed: April 5, 1982
    Date of Patent: July 3, 1984
    Inventor: Gerald L. Chrisope